Spondyloarthritis Studies and Treatments
Spondyloarthritis Studies and Treatments is a research topic within Rheumatology. Science Explorer counts 25k research works in it since 1950. 19.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the classification, diagnosis, and treatment of spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis. It covers the development of new classification criteria, assessment of disease activity, use of biologic therapies such as tumor necrosis factor inhibitors and interleukin-17 inhibitors, and the impact of genetic factors like HLA-B27.
- Spondyloarthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Classification Criteria
- Treatment Recommendations
- Inflammatory Back Pain
- Enthesitis
- Tumor Necrosis Factor Inhibitors
- HLA-B27
- Interleukin-17
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 5k per year above
- Top-10% rate
- 19.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +34% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Spondyloarthritis Studies and Treatments research?
By volume, China and the United States publish the most (1.1k and 767 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.1k works
- 2 United States 767 works
- 3 United Kingdom 366 works
- 4 Italy 288 works
- 5 Germany 275 works
- 6 Türkiye 266 works
- 7 France 261 works
- 8 Spain 241 works
- 9 Japan 213 works
- 10 India 164 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Spondyloarthritis Studies and Treatments research?
By volume in 2022–2025, Charité - Universitätsmedizin Berlin publishes the most Spondyloarthritis Studies and Treatments research, followed by Hacettepe University and Leiden University Medical Center.
By volume, 2022–2025
- 1 Charité - Universitätsmedizin BerlinGermany 32 works
- 2 Hacettepe UniversityTürkiye 26 works
- 3 Leiden University Medical CenterNetherlands 22 works
- 4 Rheumazentrum RuhrgebietGermany 22 works
- 5 InsermFrance 20 works
- 6 Peking UniversityChina 19 works
- 7 Ruhr University BochumGermany 19 works
- 8 Brigham and Women's HospitalUnited States 18 works
- 9 University of TorontoCanada 18 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 16 works
Who are the leading researchers in Spondyloarthritis Studies and Treatments?
The most-cited researchers publishing on Spondyloarthritis Studies and Treatments include Jasvinder A. Singh, Rachelle Buchbinder and Elı́as Campo.
- 1 Jasvinder A. Singh United States 4.7k citations
- 2 Rachelle Buchbinder Australia 3.5k citations
- 3 Elı́as Campo Spain 3k citations
- 4 Stefan Schreiber Germany 2.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Spondyloarthritis Studies and Treatments research done?
The largest centres of Spondyloarthritis Studies and Treatments research in 2022–2025 are Beijing (China), Paris (France), Shanghai (China) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Herne.
Largest cities, 2022–2025
Where it is the local speciality
- HerneDE · 22.1 works202×
Location quotient: how much more of its research is in Spondyloarthritis Studies and Treatments than the world average.
Where is the best place to study Spondyloarthritis Studies and Treatments?
Among universities, judged by research, Ruhr University Bochum, University of Verona and Oregon Health & Science University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Ruhr University BochumGermany | 62.7 | 19.6% | 8.4× | 19 | +151.3% |
| 2 | University of VeronaItaly | 61.9 | 25.4% | 9.4× | 13 | +100.8% |
| 3 | Oregon Health & Science UniversityUnited States | 56.9 | 31.3% | 7.3× | 13 | +59.7% |
| 4 | University of Rome Tor VergataItaly | 56.1 | 26.6% | 6.2× | 11 | +158.6% |
| 5 | University of Occupational and Environmental Health JapanJapan | 55.2 | 32.9% | 25.8× | 8 | -1.4% |
| 6 | Tunis El Manar UniversityTunisia | 54.4 | 12.7% | 10.4× | 10 | +149.5% |
| 7 | Izmir Kâtip Çelebi UniversityTürkiye | 53.9 | 11.6% | 12.9× | 11 | +310.1% |
| 8 | Capital Medical UniversityChina | 52.9 | 29.7% | 3.7× | 12 | +197.3% |
| 9 | Guangzhou University of Chinese MedicineChina | 52.2 | 24.4% | 8.8× | 9 | +100.8% |
| 10 | King's College LondonUnited Kingdom | 50.8 | 37.7% | 2.9× | 12 | +31.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Spondyloarthritis Studies and Treatments research growing?
Output in 2018–2022 was 34% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Spondyloarthritis Studies and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.